Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN05
- Pharmacological subgroupN05A
- Chemical subgroupN05AN
- Chemical substanceN05AN01Lithium
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 19 medicines
CBG-MEB · 8 medicines
AIFA · 4 medicines
SFDA · 3 medicines · Historical list
TFDA · 3 medicines
AEMPS · 2 medicines
PHARMAC · 2 medicines
HALMED · 1 medicine
HSA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
134 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Lithium | United States | Status unknown | |||
| Lithium Citrate | United States | 300MG CARBONATE/5ML, 300MG CARBONATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | syrup | Marketed | Sciegen Pharms |
| Lithium Carbonate | United States | 300MG | tablet | Marketed | Hikma |
| Lithium Carbonate | United States | 300MG, 450MG | tablet, extended release | Marketed | Hikma Intl Pharms |
| Lithium Carbonate | United States | 150MG, 300MG, 600MG | capsule | Marketed | Pharmobedient |
| Lithium carbonicum | United States | Status unknown | |||
| Lithiumcarbonaat Teva 200 mg, tabletten | Netherlands | Tablet | Authorised | Teva Nederland B.V. | |
| Lithiumcarbonaat Teva 300 mg, tabletten | Netherlands | Tablet | Authorised | Teva Nederland B.V. | |
| Lithiumcarbonaat Teva 400 mg, tabletten | Netherlands | Tablet | Authorised | Teva Nederland B.V. | |
| Lithobid | United States | 300MG | tablet, extended release | Marketed | Ani Pharms |
| Apo-Lithium Carbonate | Canada | 150 MG | Capsule | Marketed | Apotex INC |
| PMS-Lithium Carbonate - Cap 150MG | Canada | 150 MG | Capsule | Marketed | Pharmascience INC |
| Lithane | United States | 300MG | tablet | Not marketed | Bayer Pharms |
| Lithium Carb | United States | Status unknown | |||
| Apo-Lithium Carbonate | Canada | 300 MG | Capsule | Not marketed | Apotex INC |
| Lithonate | United States | 300MG CARBONATE/5ML | syrup | Not marketed | Solvay |
| Lithonate | United States | 300MG | capsule | Not marketed | Solvay |
| Lithotabs | United States | 300MG | tablet | Not marketed | Solvay |
| Lidin Tablets 300MG (Lithium Carbonate) | Taiwan | 錠劑 | Authorised | 優良化學製藥股份有限公司 | |
| BM Lithium chloride (Lith Mur) | United States | Status unknown | |||
| PMS-Lithium Carbonate - Cap 300MG | Canada | 300 MG | Capsule | Not marketed | Pharmascience INC |
| PMS-Lithium Carbonate - Cap 600MG | Canada | 600 MG | Capsule | Not marketed | Pharmascience INC |
| Euro Lithium | Canada | 300 MG | Capsule | Cancelled | Euro-Pharm International Canada INC |
| Euro Lithium | Canada | 150 MG | Capsule | Cancelled | Euro-Pharm International Canada INC |
| Eskalith | United States | 300MG | capsule | Not marketed | Noven Therap |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.